“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
Guy Brusselle(Ghent University Hospital), Ivo Abraham(University of Pennsylvania), Renaud Louis(Centre Hospitalier Universitaire de Liège), Alain Michils(Erasmus Hospital), Charles Pilette(UCLouvain), Stefaan Vancayzeele(Novartis (Belgium)), Boudewijn Van de Maele(AZ Sint-Jan), Lieven Dupont(KU Leuven), Pascal Lecomte(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Karen MacDonald(Matrix Research (United States)), Christopher S. Lee, MinKyoung Song(Matrix Research (United States)), Sandra Gurdain(Novartis (Belgium)), Christine Hermans(Novartis (Belgium)), Alain Delobbe(Centre hospitalier régional de la Citadelle)
Cited by 198
Related Papers
ESA CCI Soil Moisture for improved Earth system understanding: State-of-the art and future directions
|Remote Sensing of Environment|2017|1.5k
Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks
|Nature Genetics|2017|591
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
|Journal of Cardiac Failure|2024|357
Eosinophilic and Noneosinophilic Asthma
|CHEST Journal|2021|262